GILEAD SCIENCES, INC. Logo

GILEAD SCIENCES, INC.

A research-based biopharmaceutical company focused on virology, oncology & inflammation.

GILD | US

Overview

Corporate Details

ISIN(s):
US3755581036
LEI:
Country:
United States of America
Address:
333 LAKESIDE DR, 94404 FOSTER CITY

Description

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes innovative medicines to address unmet medical needs. The company's primary focus is on virology, with a portfolio of transformative therapies for life-threatening diseases such as HIV/AIDS and viral hepatitis. Gilead is also expanding its impact in oncology and inflammation, maintaining a diverse pipeline of clinical programs across these key therapeutic areas. The company invests in scientific research to develop treatments for some of the world's most challenging diseases, aiming to improve the lives of patients globally.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-12-01 19:11
FORM 4
English ZIP 7.3 KB
2025-12-01 17:54
FORM 4
English ZIP 7.5 KB
2025-12-01 17:50
FORM 4
English ZIP 7.2 KB
2025-12-01 17:36
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
English ZIP 8.2 KB
2025-11-28 14:05 English ZIP 7.1 KB
2025-11-28 14:02 English ZIP 7.0 KB
2025-11-26 17:16 English ZIP 7.1 KB
2025-11-19 09:30
FORM 8-K
English ZIP 64.3 KB
2025-11-18 20:00
FORM 4
English ZIP 6.7 KB
2025-11-18 19:51
FORM 4
English ZIP 7.8 KB
2025-11-17 17:06 English ZIP 7.2 KB
2025-11-17 17:05 English ZIP 7.3 KB
2025-11-13 20:36
FORM 4
English ZIP 8.3 KB
2025-11-13 18:07 English ZIP 6.8 KB
2025-11-13 17:44 English ZIP 7.9 KB

Automate Your Workflow. Get a real-time feed of all GILEAD SCIENCES, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for GILEAD SCIENCES, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for GILEAD SCIENCES, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Aprogen, Inc Logo
Develops and manufactures biologic medicines, including biosimilars and novel drugs.
South Korea
007460
Develops drugs for intractable diseases by regulating oxidative stress and CAFs.
South Korea
293780
Aptamer Sciences Inc Logo
Clinical-stage company developing aptamer-based therapeutics for oncology.
South Korea
291650
Aptorum Group Ltd Logo
Clinical-stage biopharma developing therapeutics for oncology and infectious diseases.
United States of America
APM
Aquestive Therapeutics, Inc. Logo
Pharmaceutical company developing oral film medicines for CNS and allergic reactions.
United States of America
AQST
Arbutus Biopharma Corp Logo
Clinical-stage biopharma company developing a functional cure for chronic Hepatitis B.
United States of America
ABUS
Arcellx, Inc. Logo
A clinical-stage biotech company developing immunotherapies for cancer and autoimmune diseases.
United States of America
ACLX
Arctic Bioscience Logo
Develops pharmaceutical and nutraceutical products from marine membrane lipids.
Norway
ABS
ArcticZymes Technologies Logo
Develops and manufactures novel recombinant enzymes from Arctic marine organisms.
Norway
AZT
Arcturus Therapeutics Holdings Inc. Logo
A commercial-stage mRNA medicines company focused on rare and infectious diseases.
United States of America
ARCT

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.